Search for a Prion-Specific Nucleic Acid

ABSTRACT Diversity of prion strains was attributed to an elusive nucleic acid, yet a search spanning nearly two decades has failed to identify a prion-specific polynucleotide. In our search for a prion-specific nucleic acid, we analyzed nucleic acids in purified fractions from the brains of Syrian hamsters infected with Sc237 prions. Purification of Sc237 prions removed nucleic acids larger than 50 nucleotides as measured by return refocusing electrophoresis (RRGE). To determine the size of the largest polynucleotide present in purified fractions at an abundance of one molecule per infectious (ID50) unit, we measured prions present after inoculation. In order to account for the rapid clearance of prions after intracerebral inoculation, we determined the number of PrPSc molecules and ID50 units of prions that were retained in brain. Factoring in clearance after inoculation, we estimate that the largest polynucleotide present in our purified fractions at one molecule per ID50 unit is ≈25 nucleotides in length. In the same fractions, there were ≈3,000 protease-resistant PrPSc molecules per ID50 unit after accounting for clearance of PrPSc following inoculation. We compared the resistance of Sc237 and 139H prions to inactivation by UV irradiation at 254 nm. Irradiation of homogenates and microsomes diminished prion infectivity by a factor of ≈1,000 but did not alter the strain-specified properties of the Sc237 and 139H prions. The data reported here combined with the production of synthetic prions argue that the 25-mer polynucleotides found in purified prion preparations are likely to be host encoded and of variable sequence; additionally, these 25-mers are unlikely to be prion specific.

[1]  F. Slack,et al.  siRNA. A guide for RNA silencing. , 2002, Chemistry & biology.

[2]  F. Cohen,et al.  Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.

[3]  F E Cohen,et al.  A synthetic peptide initiates Gerstmann-Sträussler-Scheinker (GSS) disease in transgenic mice. , 2000, Journal of molecular biology.

[4]  S. Prusiner,et al.  3 Bioassays of Prions , 1999 .

[5]  C. Gabus,et al.  The Prion Protein Has RNA Binding and Chaperoning Properties Characteristic of Nucleocapsid Protein NCp7 of HIV-1* , 2001, The Journal of Biological Chemistry.

[6]  H. Narang A Critical Review of the Nature of the Spongiform Encephalopathy Agent: Protein Theory Versus Virus Theory 1 , 2002, Experimental biology and medicine.

[7]  J. Chabry,et al.  Specific inhibition of pathological prion protein accumulation by small interfering RNAs , 2003, Journal of Cell Science.

[8]  R. Kimberlin Slow virus diseases of animals and man. , 1976 .

[9]  Schlesinger Rw THE MECHANISM OF ACTIVE CEREBRAL IMMUNITY TO EQUINE ENCEPHALOMYELITIS VIRUS : II. THE LOCAL ANTIGENIC BOOSTER EFFECT OF THE CHALLENGE INOCULUM , 1949 .

[10]  J. Aiken,et al.  Presence of mitochondrial D-loop DNA in scrapie-infected brain preparations enriched for the prion protein , 1990, Journal of virology.

[11]  S. Prusiner,et al.  Properties of scrapie prion protein liposomes. , 1988, The Journal of biological chemistry.

[12]  S. Prusiner,et al.  Replication of distinct scrapie prion isolates is region specific in brains of transgenic mice and hamsters. , 1992, Genes & development.

[13]  B. Chesebro A Fresh Look at BSE , 2004, Science.

[14]  S. Prusiner,et al.  Scrapie prions aggregate to form amyloid-like birefringent rods , 1983, Cell.

[15]  S. Prusiner,et al.  Complete Penetrance of Creutzfeldt-Jakob Disease in Libyan Jews Carrying the E200K Mutation in the Prion Protein Gene , 1995, Molecular medicine.

[16]  R. Marsh,et al.  Comparison of scrapie and transmissible mink encephalopathy in hamsters. II. Clinical signs, pathology, and pathogenesis. , 1975, The Journal of infectious diseases.

[17]  H. Wiśniewski,et al.  Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins , 1987, Journal of virology.

[18]  C. Péchoux,et al.  The prion protein has DNA strand transfer properties similar to retroviral nucleocapsid protein. , 2001, Journal of molecular biology.

[19]  E. J. Field The scrapie agent. , 1967, Lancet.

[20]  S. Prusiner,et al.  Purified scrapie prions resist inactivation by procedures that hydrolyze, modify, or shear nucleic acids. , 1987, Virology.

[21]  F E Cohen,et al.  A conformational transition at the N terminus of the prion protein features in formation of the scrapie isoform. , 1997, Journal of molecular biology.

[22]  S. Prusiner,et al.  A Change in the Conformation of Prions Accompanies the Emergence of a New Prion Strain , 2002, Neuron.

[23]  R. L. Chandler Encephalopathy in mice produced by inoculation with scrapie brain material. , 1961, Lancet.

[24]  J. Wilesmith,et al.  The Neuropathology and Epidemiology of Bovine Spongiform Encephalopathy , 1995, Brain pathology.

[25]  S. Mann,et al.  Ciba Foundation Symposium , 1997 .

[26]  S. Prusiner,et al.  Scrapie prion rod formation in vitro requires both detergent extraction and limited proteolysis , 1991, Journal of virology.

[27]  Schlesinger Rw THE MECHANISM OF ACTIVE CEREBRAL IMMUNITY TO EQUINE ENCEPHALOMYELITIS VIRUS : I. INFLUENCE OF THE RATE OF VIRAL MULTIPLICATION , 1949 .

[28]  J. Weissman,et al.  Evidence for the prion hypothesis: induction of the yeast [PSI+] factor by in vitro- converted Sup35 protein. , 2000, Science.

[29]  A. Dickinson,et al.  Biological evidence that scrapie agent has an independent genome. , 1987, The Journal of general virology.

[30]  S. Duvezin-Caubet,et al.  Amyloid aggregates of the HET-s prion protein are infectious , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  S. Prusiner,et al.  Measurement of the scrapie agent using an incubation time interval assay , 1982, Annals of neurology.

[32]  J. Stamp,et al.  Scrapie disease of sheep. , 1961, World neurology.

[33]  R. Kimberlin,et al.  Pathogenesis of scrapie is faster when infection is intraspinal instead of intracerebral. , 1987, Microbial pathogenesis.

[34]  Jonathan O. Harris,et al.  Creutzfeldt‐Jakob disease: Patterns of worldwide occurrence and the significance of familial and sporadic clustering , 1979, Annals of neurology.

[35]  J L Marx,et al.  A virus by any other name . . . , 1985, Science.

[36]  F. L. Schaffer,et al.  Purification and properties of poliovirus. , 1959, Advances in virus research.

[37]  F. Cohen,et al.  High-level expression and characterization of a purified 142-residue polypeptide of the prion protein. , 1996, Biochemistry.

[38]  L. Court Transmissible Subacute Spongiform Encephalopathies : Prion Diseases , 1996 .

[39]  G. Bock,et al.  Novel infectious agents and the central nervous system , 1988 .

[40]  TIKVAH ALPER,et al.  Does the Agent of Scrapie Replicate without Nucleic Acid ? , 1967, Nature.

[41]  S. Prusiner,et al.  Search for a putative scrapie genome in purified prion fractions reveals a paucity of nucleic acids. , 1991, The Journal of general virology.

[42]  R. Diaz-Avalos,et al.  Protein-only transmission of three yeast prion strains , 2004, Nature.

[43]  S. Prusiner,et al.  Scrapie-infected murine neuroblastoma cells produce protease-resistant prion proteins , 1988, Journal of virology.

[44]  C. Anfinsen Principles that govern the folding of protein chains. , 1973, Science.

[45]  S. Prusiner,et al.  Viroids and prions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[46]  S. Prusiner,et al.  Prion biology and diseases. , 1999, Harvey lectures.

[47]  T. Alper,et al.  The exceptionally small size of the scrapie agent. , 1966, Biochemical and biophysical research communications.

[48]  S. Prusiner,et al.  Further analysis of nucleic acids in purified scrapie prion preparations by improved return refocusing gel electrophoresis. , 1992, The Journal of general virology.

[49]  S. Prusiner,et al.  Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity , 1996, Science.

[50]  S. Prusiner,et al.  Search for a scrapie-specific nucleic acid: a progress report. , 1988, Ciba Foundation symposium.

[51]  R. Kimberlin,et al.  Characteristics of a short incubation model of scrapie in the golden hamster. , 1977, The Journal of general virology.

[52]  J. Chapuis,et al.  Efficient and specific down-regulation of prion protein expression by RNAi. , 2003, Biochemical and biophysical research communications.

[53]  D. Gajdusek Unconventional viruses and the origin and disappearance of kuru. , 1977, Science.

[54]  S. Prusiner,et al.  Further purification and characterization of scrapie prions. , 1982, Biochemistry.

[55]  Dickinson Ag Scrapie in sheep and goats. , 1976 .

[56]  S. Supattapone Prion protein conversion in vitro , 2004, Journal of Molecular Medicine.

[57]  J. Foster,et al.  Spiroplasma sp. 16S rDNA in Creutzfeldt‐Jakob Disease and Scrapie as Shown by PCR and DNA Sequence Analysis , 2001, Journal of neuropathology and experimental neurology.

[58]  J. Collinge,et al.  Bioassays for Prions , 2004 .

[59]  R. J. Cawthorne Scrapie in sheep and goats , 1990, Veterinary Record.

[60]  L. Adams,et al.  Ultrasensitive silver‐based color staining of polypeptides in polyacrylamide gels , 1981 .

[61]  R. Rohwer,et al.  The scrapie agent: "a virus by any other name". , 1991, Current topics in microbiology and immunology.

[62]  R. Rubenstein,et al.  Small, highly structured RNAs participate in the conversion of human recombinant PrP(Sen) to PrP(Res) in vitro. , 2003, Journal of molecular biology.

[63]  R. Latarjet,et al.  Inactivation of the Scrapie Agent by Near Monochromatic Ultraviolet Light , 1970, Nature.

[64]  J. Chapman,et al.  The risk of developing Creutzfeldt‐Jakob disease in subjects with the PRNP gene codon 200 point mutation , 1994, Neurology.

[65]  S. Prusiner,et al.  Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice , 2002, Nature Biotechnology.

[66]  S. Prusiner Novel proteinaceous infectious particles cause scrapie. , 1982, Science.

[67]  S. Prusiner,et al.  Prion protein conformation in a patient with sporadic fatal insomnia. , 1999, The New England journal of medicine.

[68]  S. Prusiner,et al.  Molecular biology of prion diseases , 1991, Science.

[69]  R. Marsh,et al.  Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy , 1994, Journal of virology.

[70]  S. Supattapone,et al.  RNA molecules stimulate prion protein conversion , 2003, Nature.

[71]  H. J. F. CAIRNS,et al.  Intracerebral Inoculation of Mice: Fate of the Inoculum , 1950, Nature.

[72]  S. Prusiner 2 Development of the Prion Concept , 1999 .

[73]  F. Cohen,et al.  Synthetic Mammalian Prions , 2004, Science.

[74]  D. C. Dashfield HER MAJESTY'S STATIONERY OFFICE , 1954 .

[75]  F. Cohen,et al.  Pathway Complexity of Prion Protein Assembly into Amyloid* , 2002, The Journal of Biological Chemistry.

[76]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[77]  F. Cohen,et al.  Mutant PrPSc Conformers Induced by a Synthetic Peptide and Several Prion Strains , 2004, Journal of Virology.

[78]  F. Cohen,et al.  Strain-specified characteristics of mouse synthetic prions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[79]  Y. Cordeiro,et al.  DNA Converts Cellular Prion Protein into the β-Sheet Conformation and Inhibits Prion Peptide Aggregation* , 2001, The Journal of Biological Chemistry.

[80]  C. Weissmann,et al.  A 'unified theory' of prion propagation , 1991, Nature.

[81]  Roger Cooke,et al.  Conformational variations in an infectious protein determine prion strain differences , 2004, Nature.

[82]  A. D. Hershey,et al.  INDEPENDENT FUNCTIONS OF VIRAL PROTEIN AND NUCLEIC ACID IN GROWTH OF BACTERIOPHAGE , 1952, The Journal of general physiology.

[83]  S. Prusiner,et al.  Purified scrapie prions resist inactivation by UV irradiation , 1987, Journal of virology.